Site updated at Wednesday, 22 June 2016

Living with Dementia

Amyloid Targeting Treatment

Beta secretase inhibitors to treat Alzheimer’s disease

With each new amyloid-targeting treatment for Alzheimer’s disease that has been developed, there has been a corresponding concern. For example, antibodies targeting amyloid-β peptide (Aβ) produce inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.

Beta secretase 1… Beta secretase inhibitors to treat Alzheimer’s disease   

Living With Dementia

progression of pd1 - neurologic disorder1 - late-onset alzheimer's disease4 - lipitor1 - structural imaging1 - progressive movement disorder2 - dementia patients8 - harvard medical school1 - cognitive decline19 - impaired memory1 - alzheimer's32 - anticholinergics1 - syndrome of dementia1 - magnetic resonance spectroscopy1 - thyroid disease1 - delirious episode1 - amyloid precursor protein6 - metabolic syndrome1 - neuroanatomical changes1 - vision1 - effective aging1 - learning skills1 - eye tremor1 - deep-brain stimulation3 - inflammation1 - short-term memory problems1 - abnormal tau protein1 - symptoms of parkinson's disease1 - omega-3s1 - ziveri1 -